Corporate Finance

Vator Securities focuses on identifying and financing growth companies as they expand and develop into tomorrow’s market leaders.

read more

About Us

Vator Securities executes on opportunities that accelerate growth for its client companies whilst delivering results to the firm’s sophisticated investor clientele.

read more

On October 26th, Vator Securities arranged the Vator Securities Life Science Summit, a unique healthcare conference where we present some of the most interesting and innovative growth companies in Sweden, bringing together industry leaders, entrepreneurs and top investors.

The participating companies were BoneSupport, SciBase, BioArctic, Immunovia, Cavis Technologies, ExpreS2ion Biotech, CombiGene, SenzaGen and AlgoDx.

Watch the presentations from the event

Vator Securities Sole Global Coordinator and Sole Bookrunner in Trustscale AB’s Private Placement through a primary and secondary equity offering to Priveq

Trustscale AB and its operating subsidiary group Verisec International is a global encryption company with a tech platform used by banks and payment providers. Trustscale offers Payment Security and User Authentication to create trust between banks, payment providers, merchants, and consumers through safe digital transactions.

A global regulatory paradigm shift now disrupts status quo and triggers payment encryption services to transform from today’s on premises, single client, market to a new outsourced, cloud based and globally scalable offering.

read more

Vator Securities advises Amniotics on 36 MSEK Rights Issue

Amniotics is a biopharma company focusing on mesenchymal stem cells (MSC) from amniotic fluid. The company was born out of the discovery of a novel source of stem cells in full-term amniotic fluid.

Based on a decade of research at the internationally recognized Lund University Stem Cell Centre and the Skåne University Hospital of Lund, the company is pioneering the harvesting and propagation of tissue specific neonatal quality mesenchymal stem cells (MSC). These stem cells have unique properties for applications in regenerative medicine.

read more

Vator Securities advises SeaTwirl on 64.5 MSEK Rights Issue

SeaTwirl is a Swedish energy tech company in wind power with the vision to become global leader in floating offshore wind farms. SeaTwirl’s unique floating vertical-axis wind turbine is simple and robust with few moving parts. This suits the conditions at sea and minimizes the need for maintenance, which leads to less downtime and operating hours. These are key requirements for reducing the costs associated with the production of energy.

On the back of the successfully installed 30 kW prototype, S1, which has been operating efficiently since 2015, SeaTwirl is focusing on the development of SX, the next generation floating wind turbine with +10MW turbine power. In parallel with the development of SX, the company intends to continue improving efficiency and production of the S2x wind turbine in Norway.

read more

Vator Securities advises Stardots on 15 MSEK Private Placement

Stardots is a deep tech company that brings together engineers and mathematicians with neurologists and life-science developers. The company’s initial focus is on Parkinson Disease, where the company’s digital platform, ANLIVA™, through mathematical models, sensor data and AI, analyses typical symptoms through the patient’s smartphone.

This is transformed into quantifiable symptom markers used for monitoring disease progression and optimizing treatment. Caregivers receive analysis, statistics and treatment suggestions based on the patient’s markers, allowing for individualized telemedicine treatment. Stardots’ vision is that its digital health platform ANLIVA™ will become a new standard for objective, equal, globally accessible, and cost-effective Parkinson’s care.

read more

More News